PILR-alpha Antibody (36H2)
Novus Biologicals, part of Bio-Techne | Catalog # DDX0230P-100
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Rat IgG2A Clone # 36H2
Concentration
0.5 mg/ml
Product Specifications
Immunogen
FDFO3 was used as immunogen.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Scientific Data Images for PILR-alpha Antibody (36H2)
Western Blot: PILR-alpha Antibody (36H2) [DDX0230P-100]
Western Blot: PILR-alpha Antibody (36H2) [DDX0230P-100] - FDFO3 is a cell-surface monomeric glycoproteinFlow Cytometry: PILR-alpha Antibody (36H2) [DDX0230P-100]
Flow Cytometry: PILR-alpha Antibody (36H2) [DDX0230P-100] - Surface FACS staining of human PBMCFlow Cytometry: PILR-alpha Antibody (36H2) [DDX0230P-100]
Flow Cytometry: PILR-alpha Antibody (36H2) [DDX0230P-100] - An Ig-SF inhibitory receptorApplications for PILR-alpha Antibody (36H2)
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Immunoprecipitation
1:10-1:500
Western Blot
1:100-1:2000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Ion exchange chromatography
Formulation
Tris-NaCl (pH 8.0)
Preservative
No Preservative
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: PILR-alpha
Long Name
Paired-Ig-likeType 2 Receptor alpha
Alternate Names
FDF03, PILRA, PILRalpha
Gene Symbol
PILRA
Additional PILR-alpha Products
Product Documents for PILR-alpha Antibody (36H2)
Product Specific Notices for PILR-alpha Antibody (36H2)
This product is manufactured by Eurobio Scientific (formerly Dendritics) and distributed by Novus Biologicals.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...